Pharma Reviews: Indian pharma-biotech cos gear up to capitalise on current US affordable drug pricing norms

The US government's endeavour to reduce cost of drug and the new American Health Care Acts are viewed by Indian pharma-biotech companies and ...
Read more: Indian pharma-biotech cos gear up to capitalise on current US affordable drug pricing norms